Barcelona

• First in Human Study of TOS-358 in Adults with Soid Tumors Recruiting
  2023-505346-26-01 7 2024-02-19 9 main solid tumors – colorectal, cervical, endometrial, gastric, urot
• An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced … Recruiting
  2023-503865-48-00 4 2024-02-16 Locally Advanced or Metastatic Non-Small Cell Lung Cancer
• Trial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced … Recruiting
  2024-517363-24-00 4 2024-02-16 Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian,
• An Open-label Study of XEN1101 in Epilepsy Recruiting
  2022-502282-24-00 5 2024-02-14 Primary generalized tonic-clonic seizures
• Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting
  2023-506604-18-00 1 2024-02-14 Triple negative breast cancer
• Ph1/2 study of AVB-101 in Subjects with Frontotemporal Dementia with Progranulin Mutations (FTD-GRN) Recruiting
  2023-509444-10-00 7 2024-02-08 Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
• Alpelisib for the treatment of lymphatic malformations associated with a PIK3CA mutation Recruiting
  2023-504146-60-00 10 2024-02-07 lymphatic malformations associated with PIK3CA mutation
• Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy … Recruiting
  2022-500531-36-00 4 2024-02-02 Type 1 diabetes mellitus
• Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting
  2023-509142-35-00 6 2024-01-29 Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
• A Phase 1/2 study of Enzomenib (DSP-5336) in Adult Patients with Acute leukemia Recruiting
  2022-502741-10-00 7 2024-01-26 Acute Leukemia with Mixed Lineage Leukemia (MLL)-rearrangement or Nucl
• A study to Evaluate Efficacy and Safety of Giredestrant Compared with Fulvestrant (plus a CDK4/6 inhibitor), in Participants with ER+ HER2-N … Recruiting
  2022-502980-39-00 5 2024-01-25 Estrogen receptor (ER)-positive, HER2-negative advanced breast cancer
• IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-contr … Recruiting
  2023-506620-87-00 11 2024-01-25 Advanced Breast Cancer in older patients
• Multicenter Phase 2 study to evaluate the efficacy and safety of Cetuximab in combination with Encorafenib plus Binimetinib as induction tre … Recruiting
  2022-502413-29-00 4 2024-01-22 BRAF V600E mutated and microsatellite stable (MSS) advanced colorectal
• FIRST IN-HUMAN STUDY EVALUATING THE EFFECT OF VARIOUS DOSES OF ODM-212 IN SUBJECTS WITH SELECTED ADVANCED SOLID TUMOURS Recruiting
  2022-503061-29-00 7 2024-01-22 Neoplasms benign malignant and unspecified (incl cysts and polyps). Me
• A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppressio … Recruiting
  2023-506879-98-00 6 2024-01-22 Renal transplantation
• DS-1103a Combination Therapy First-in-human (FIH) Study Recruiting
  2023-503965-48-00 1 2024-01-11 Advanced (unresectable or metastatic) human epidermal growth receptor
• PHASE II CLINICAL TRIAL TO ESTABLISH THE SAFETY OF THE USE OF EXPANDED ALLOGENEIC FETAL UMBILICAL CORD STEM MESENCHYMAL CELLS IN PRETERM PAT … Recruiting
  2024-516677-79-00 4 2024-01-11 Premature patients with bronchopulmonary dysplasia
• A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part … Recruiting
  2022-503092-28-00 5 2024-01-08 Relapsed/Refractory Follicular Lymphoma
• A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RV … Recruiting
  2023-505911-19-00 4 2024-01-05 Acute Myeloid Leukemia
• Clinical trial of the efficacy and safety of nicotinamide in patients with diabetes mellitus type 2 and liver fibrosis Recruiting
  2023-504100-28-00 4 2024-01-02 Hepatic fibrosis
• Dose-Ranging Efficacy Study of rapamycin cream applied topically in subjects diagnosed with port wine stains Recruiting
  2025-520821-19-00 4 2024-01-02 Subjects diagnosed with port wine stains
• A study to test how effective belumosudil tablets are for treating adult participants with chronic lung allograft dysfunction Recruiting
  2023-503462-23-00 5 2023-12-28 Lung transplant rejection
• A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors. Recruiting
  2023-504807-94-00 7 2023-12-26 Breast Cancer; Advanced solid tumors including but not limited to gyne
• A Study Evaluating the Efficacy and Safety of Inavolisib Plus Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for SC use) versus plac … Recruiting
  2022-502046-28-00 5 2023-12-22 HER2-Positive, PIK3CA Mutated, Locally Advanced or Metastatic Breast C

Showing 1,369–1,392 of 3,391 trials